Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Bristol Myers SquibbBMY | Open-market sale | 04/01 | 04/02 | 30,000 sh2 trades | $61.67avg. | $1,850,016.45 | −15.9% | |
David V. ElkinsEVP, CFO | Bristol Myers SquibbBMY | Open-market sale | 25/09/02 | 25/09/03 | 56,000 sh | $47.33 | $2,650,480 | −25.1% |
Bartie Wendy ShortEVP, Corporate Affairs | Bristol Myers SquibbBMY | Open-market sale | 25/08/02 | 25/08/05 | 378 sh | $44.23 | $16,718.94 | −6.9% |
Benjamin HickeyPresident, RayzeBio Org | Bristol Myers SquibbBMY | Open-market sale | 25/05/09 | 25/05/13 | 97.39 sh | $38.01 | $3,701.79 | −100.0% |
Samit HirawatEVP,Chief Med.Offr.,Drug Dev | Bristol Myers SquibbBMY | Open-market buy | 25/04/25 | 25/04/29 | 4,250 sh | $47.58 | $202,215 | +5.4% |
Bristol Myers SquibbBMY | Open-market buy | 25/02/20 | 25/02/21 | 2,000 sh | $55.05 | $110,100 | +1.9% | |
Samit HirawatEVP,Chief Med.Offr.,Drug Dev | Bristol Myers SquibbBMY | Open-market buy | 25/02/14 | 25/02/19 | 1,823.49 sh | $54.84 | $100,000.19 | +2.9% |
Phil M. HolzerSVP and Controller | Bristol Myers SquibbBMY | Open-market sale | 24/11/04 | 24/11/05 | 700 sh | $55.62 | $38,934 | −5.6% |
Samit HirawatEVP,Chief Med.Offr.,Drug Dev | Bristol Myers SquibbBMY | Open-market buy | 24/11/01 | 24/11/05 | 1,830 sh | $54.68 | $100,064.4 | +3.0% |
Bristol Myers SquibbBMY | Open-market buy | 23/12/05 | 23/12/07 | 2,000 sh | $49.78 | $99,560 | +2.5% | |
Bristol Myers SquibbBMY | Open-market buy | 23/11/28 | 23/11/30 | 3,071 sh | $48.86 | $150,049.06 | +4.0% | |
Theodore R. Samuels IIDirector | Bristol Myers SquibbBMY | Open-market buy | 23/11/20 | 23/11/21 | 8,500 sh | $49.81 | $423,385 | +31.5% |
Ann PowellEVP, Chief Human Resources | Bristol Myers SquibbBMY | Open-market sale | 23/08/24 | 23/08/28 | 17,986 sh | $61.25 | $1,101,642.5 | −39.2% |
Robert M. PlengeEVP, Chief Research Officer | Bristol Myers SquibbBMY | Open-market sale | 23/08/03 | 23/08/07 | 732 sh | $61.14 | $44,754.48 | −10.0% |
Rupert VesseyEVP & President, Research | Bristol Myers SquibbBMY | Open-market sale | 23/05/03 | 23/05/04 | 50,385 sh | $67.06 | $3,378,818.1 | −51.3% |
Giovanni CaforioBoard Chair and CEO | Bristol Myers SquibbBMY | Open-market sale | 23/02/06 | 23/02/08 | 240,000 sh | $74.65 | $17,916,000 | −50.4% |
Ann PowellEVP, Chief Human Resources | Bristol Myers SquibbBMY | Open-market sale | 23/02/06 | 23/02/08 | 11,183 sh | $74.69 | $835,258.27 | −32.7% |